U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
171331171331Improving Health Behaviors Through Telephone Linked CareCompletedNo Results AvailableDiet|Physical Activity|Smoking|Alcohol AbuseBehavioral: Telephone Linked Care - Behavior Change Counseling System|Behavioral: Telephone-linked behavioral counselinghttps://ClinicalTrials.gov/show/NCT00314197
171332171332Quetiapine Fumarate Bipolar Maintenance MonotherapyCompletedNo Results AvailableBipolar DisorderDrug: quetiapine fumaratehttps://ClinicalTrials.gov/show/NCT00314184
171333171333A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionCompletedNo Results AvailableOpen-angle Glaucoma|Ocular HypertensionDrug: Brinzolamide 10 mg/ml + Timolol 5 mg/ml eye drops, suspension|Drug: Dorzolamide 20 mg/ml + Timolol 5 mg/ml eye drops, solution (COSOPT)https://ClinicalTrials.gov/show/NCT00314171
171334171334A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionCompletedNo Results AvailableOpen-angle Glaucoma|Ocular HypertensionDrug: Brinzolamide 10 mg/ml + Timolol 5 mg/ml eye drops, suspension|Drug: Brinzolamide 10 mg/ml (AZOPT) eye drops, suspension|Drug: Timolol 5 mg/ml eye drops, solutionhttps://ClinicalTrials.gov/show/NCT00314158
171335171335A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVax™-JE and JE-VAXCompletedHas ResultsJapanese EncephalitisBiological: ChimeriVax™-JE|Biological: JE-VAX®https://ClinicalTrials.gov/show/NCT00314145
171336171336Safety Study of ChimeriVaxâ„¢-JE Vaccine to Prevent Japanese Encephalitis.CompletedHas ResultsEncephalitis|Japanese EncephalitisBiological: ChimeriVax-JE, Japanese Encephalitis vaccine|Biological: 0.9% Salinehttps://ClinicalTrials.gov/show/NCT00314132
171337171337Natural History and Biology of Skin Neurofibromas in Neurofibromatosis Type 1CompletedNo Results AvailableNeurofibromas|Neurofibromatosis Type 1https://ClinicalTrials.gov/show/NCT00314119
171338171338Chemotherapy, Irradiation, Cell Infusions, and Interleukin-2 to Treat Metastatic MelanomaCompletedHas ResultsMetastatic MelanomaBiological: Melanoma Reactive TIL|Drug: Cyclophosphamide|Biological: IL-2|Drug: Fludarabine|Radiation: 1200 total body irradiation (TBI)https://ClinicalTrials.gov/show/NCT00314106
171339171339RFT-5-dgA in Patients With Metastatic MelanomaCompletedNo Results AvailableMetastatic MelanomaDrug: RFT5pdgAhttps://ClinicalTrials.gov/show/NCT00314093
171340171340Treatment of Survivors After Botulism OutbreakCompletedNo Results AvailableRespiratory Failure|BotulismDrug: Botulinum AntiToxin|Procedure: neuro-electrophysiologic study, repetitive nerve stimulation|Procedure: Protocol early weaning ventilator after recovery of repetitive nerve stimulation and stable negative inspiratory pressurehttps://ClinicalTrials.gov/show/NCT00314080
171341171341Evaluation of Case Management to Improve the Outpatient Care of Alcohol-related DisordersCompletedNo Results AvailableAlcohol-related DisordersProcedure: Online Comprehensive Quality Management System (CQM) of alcohol-related disorders in primary care|Procedure: Physician training|Procedure: Practice team traininghttps://ClinicalTrials.gov/show/NCT00314067
171342171342Study Evaluating the Safety of HCV-796 in Subjects With Liver Disease and in Healthy AdultsCompletedNo Results AvailableHepatitis C|Hepatic InsufficiencyDrug: HCV-796https://ClinicalTrials.gov/show/NCT00314054
171343171343Study Evaluating the Tolerance of Conjugate Meningococcal C Vaccine in InfantsCompletedNo Results AvailableMeningitis, MeningococcalBiological: Meningococcal C|Biological: DTP/Hibhttps://ClinicalTrials.gov/show/NCT00314041
171344171344Effectiveness of HIV Risk Reduction Program Among African American MenCompletedNo Results AvailableSexually Transmitted Diseases|HIVBehavioral: Focus on the Future|Other: Control standard of care treatmenthttps://ClinicalTrials.gov/show/NCT00314028
171345171345Evaluation of the Success Rate of Immediately Loaded ImplantsRecruitingNo Results AvailableDental ImplantsProcedure: Evaluation of the success rate of implants|Procedure: Questionnaireshttps://ClinicalTrials.gov/show/NCT00314015
171346171346Catheter Thrombectomy in Patients With Massive Pulmonary EmbolismTerminatedNo Results AvailablePulmonary EmbolismDevice: Mechanical Thrombectomyhttps://ClinicalTrials.gov/show/NCT00314002
171347171347Evaluation of Osseo-integration After Placement of Dental Implants With Patients Receiving Radiotherapy for Buccopharyngeal OncologyRecruitingNo Results AvailableDental ImplantsProcedure: Evaluation of the success rate of implantshttps://ClinicalTrials.gov/show/NCT00313989
171348171348Study to Compare Double-dose Betaferon to the Approved Dose, for Patients With Early Secondary Progressive Multiple Sclerosis (SPMS)WithdrawnNo Results AvailableMultiple SclerosisDrug: Interferon beta-1b (Betaferon/Betaseron, BAY86-5046)|Drug: Interferon beta-1b (Betaferon/Betaseron, BAY86-5046)https://ClinicalTrials.gov/show/NCT00313976
171349171349MAST - Magnesium for Sickle Cell Acute Crisis in ChildrenCompletedNo Results AvailableAnemia, Sickle CellDrug: Magnesium Sulfate|Drug: Normal Salinehttps://ClinicalTrials.gov/show/NCT00313963
171350171350Immunogenicity and Safety of Hepatitis A Vaccine Given at the Same Time of Measles, Mumps, Rubella Combined VaccineCompletedNo Results AvailableMeasles|Mumps|Rubella|Hepatitis ABiological: Inactivated Hep A vaccine; Attenuated Measles Mumps Rubella|Biological: Attenuated Measles Mumps Rubella; Inactivated Hep A vaccine|Biological: Inactivated Hep A vaccine; Attenuated Measles Mumps Rubellahttps://ClinicalTrials.gov/show/NCT00313950
171351171351SAM - Skip a Meal - Insulin Glargine, Diabetes Mellitus Type 1CompletedNo Results AvailableDiabetes Mellitus, Type 1Drug: Insulin glarginehttps://ClinicalTrials.gov/show/NCT00313937
171352171352Assessing the OAB-8 Questionnaire as a Tool to Measure Treatment OutcomeRecruitingNo Results AvailableOveractive BladderDrug: DETRUSITOLhttps://ClinicalTrials.gov/show/NCT00313924
171353171353Safety of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Tritanrix-HepB/Hibâ„¢ and OPV Given at Age 2, 4, and 6 Months.CompletedHas ResultsDiphtheria|Tetanus|Pertussis|Haemophilus Influenzae Type b|Hepatitis BBiological: DTaP-IPV-HB-PRP~T|Biological: Tritanrix-HepB/Hibhttps://ClinicalTrials.gov/show/NCT00313911
171354171354Effect of Sildenafil on Quality of Sexual Life in Mild to Normally Sexually Functioning MalesRecruitingNo Results AvailableErectile DysfunctionDrug: sildenafil (viagra)https://ClinicalTrials.gov/show/NCT00313898
171355171355Efficacy and Safety of SR46349B in Patients With Sleep Disorders in FibromyalgiaCompletedNo Results AvailableFibromyalgia|Sleep|Chronic PainDrug: eplivanserin (SR46349)|Drug: placebohttps://ClinicalTrials.gov/show/NCT00313885
171356171356Phase III Trial of DP Followed by FOLFIRI or the Reverse Sequence in Unresectable Gastric CancerCompletedNo Results AvailableGastric Cancer|MetastasesDrug: DP|Drug: FOLFIRIhttps://ClinicalTrials.gov/show/NCT00313872
171357171357Phase II Study of Simvastatin Plus Irinotecan, Fluorouracil, and Leucovorin(FOLFIRI) for Metastatic CRCCompletedNo Results AvailableColorectal Cancer|MetastasisDrug: simvastatinhttps://ClinicalTrials.gov/show/NCT00313859
171358171358Safety and Efficacy of Buprenorphine Transdermal System in Subjects With Moderate to Severe Osteoarthritis of Hip or KneeCompletedHas ResultsOsteoarthritisDrug: Buprenorphine transdermal patch|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00313846
171359171359Safety and Effectiveness of Buprenorphine Transdermal System in Elderly Subjects With Chronic Pain: Pilot Study.CompletedNo Results AvailableChronic PainDrug: Buprenorphine transdermal delivery systemhttps://ClinicalTrials.gov/show/NCT00313833
171360171360Efficacy Of Pregabalin In Subjects With Post-Stroke Central Neuropathic PainCompletedHas ResultsCentral Neuropathic PainDrug: Pregabalin|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00313820

* Görseller ve İçerik tekif hakkına sahip olabilir